Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$129.64 - $160.7 $1,037 - $1,285
-8 Reduced 1.31%
604 $94,000
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $514 - $739
4 Added 0.66%
612 $80,000
Q1 2021

May 13, 2021

SELL
$150.19 - $173.5 $300 - $347
-2 Reduced 0.33%
608 $100,000
Q2 2020

Jul 15, 2020

SELL
$95.68 - $121.88 $191 - $243
-2 Reduced 0.33%
610 $67,000
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $87 - $152
-1 Reduced 0.16%
612 $61,000
Q4 2019

Feb 05, 2020

BUY
$117.65 - $153.73 $235 - $307
2 Added 0.33%
613 $92,000
Q4 2018

Feb 04, 2019

BUY
$115.94 - $166.74 $579 - $833
5 Added 0.83%
611 $76,000
Q1 2018

May 14, 2018

SELL
$135.59 - $157.16 $677 - $785
-5 Reduced 0.82%
606 $91,000
Q4 2017

Jan 24, 2018

BUY
$131.06 - $150.39 $1,441 - $1,654
11 Added 1.83%
611 $82,000
Q3 2017

Oct 18, 2017

BUY
$142.62 - $155.6 $85,572 - $93,360
600
600 $88,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.